“All summer long he was pinging us with emails. What are the big mysteries? This constant insatiable desire to know what was next. That never stopped.”
That’s what former Eli Lilly executive Tom Bumol remembers about his interactions with the former Microsoft billionaire Paul Allen this summer as Allen decided to start a new scientific institute, which Bumol will head, that will be dedicated to understanding the human immune system, as well as its role in cancer and in other diseases.